cdd-1

Caenorhabditis elegans

Enables RNA binding activity and cytidine deaminase activity. Involved in RNA modification; deoxycytidine catabolic process; and uridine biosynthetic process. Predicted to be located in cytosol. Expressed in intestine; pharynx; and tail. Human ortholog(s) of this gene implicated in lung non-small cell carcinoma and stomach cancer. Is an ortholog of human CDA (cytidine deaminase).

dnj-25

Caenorhabditis elegans

Predicted to enable clathrin binding activity. Involved in receptor-mediated endocytosis. Predicted to be located in cytoplasm; intracellular membrane-bounded organelle; and vesicle. Human ortholog(s) of this gene implicated in Parkinson's disease 19A. Is an ortholog of human DNAJC6 (DnaJ heat shock protein family (Hsp40) member C6).

C15F1.14

Caenorhabditis elegans

Is affected by cep-1; adr-1; and sftb-1 based on RNA-seq studies.

C17G10.14

Caenorhabditis elegans

Is affected by adr-1; etr-1; and ogt-1 based on RNA-seq studies.

C41C4.18

Caenorhabditis elegans

Is affected by prg-1; hsf-1; and glp-1 based on RNA-seq studies.

F18C5.15

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and ogt-1 based on RNA-seq studies.

F26D11.15

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and glp-1 based on RNA-seq studies.

R05F9.14

Caenorhabditis elegans

Is affected by adr-1; etr-1; and ogt-1 based on RNA-seq studies.

T23F2.9

Caenorhabditis elegans

Is affected by etr-1; hpk-1; and ogt-1 based on RNA-seq studies.

Y38E10A.33

Caenorhabditis elegans

Is affected by adr-1; olrn-1; and ogt-1 based on RNA-seq studies.